Tiffany Le

Tiffany Le is a Principal at New Enterprise Associates, where she specializes in early-stage life sciences investments with an emphasis on medtech and healthtech. Before joining this leading venture capital firm, she worked as an investor at Kaiser Permanente Ventures and served as a Senior Consultant and Associate at LEK Consulting. She holds a Bachelor of Arts in Business Economic Theory from the University of California, Los Angeles, and a Master of Business Administration from the prestigious Harvard Business School. Le currently serves as a Board Director for several prominent organizations, including Allay Therapeutics, Amber Therapeutics, FIRE1, Magenta Medical, Revelle Aesthetics, and the ExploraMed incubator. With over a decade of professional healthcare experience, she also works closely with portfolio companies like Moximed, Setpoint Medical, and Willow to advance innovations at the intersection of technology and medicine.